Averna Therapeutics

Boston, United States

Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

$85.0M raised

Jun 2024

Series A

Biotechnology Information Technology Manufacturing Medical Technical Support

Top Investors

Insight Venture Management LLC.OrbiMed Invus Innovation Endeavors JP Morgan

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Averna Therapeutics

How much funding has Averna Therapeutics raised?

Averna Therapeutics has raised $85.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.

Who are Averna Therapeutics's investors?

Averna Therapeutics's investors include Insight Venture Management, LLC., OrbiMed, Invus, Innovation Endeavors, JP Morgan.

Where is Averna Therapeutics headquartered?

Averna Therapeutics is headquartered in Boston, United States.

What does Averna Therapeutics do?

Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

What stage is Averna Therapeutics at?

Averna Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 25, 2024.

MLA

"Averna Therapeutics — Funding & Investors." VCBacked, June 25, 2024, https://www.vcbacked.co/company/averna-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Averna Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/averna-therapeutics

Wikipedia (cite web)

{{cite web |title=Averna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/averna-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 25, 2024.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K